Contineum Therapeutics, Inc. CTNM
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2024-04-05
Contineum Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 931,709 | $15.3M | 3.36% |
| BlackRock Finance, Inc. | 396,273 | $7.0M | 1.43% |
| CITADEL ADVISORS LLC | 396,354 | $6.5M | 1.43% |
| RENAISSANCE TECHNOLOGIES LLC | 67,300 | $1.1M | 0.24% |
| TWO SIGMA INVESTMENTS, LP | 30,347 | $497,387 | 0.11% |
| Point72 Asset Management, L.P. | 25,779 | $422,518 | 0.09% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.